17 completed, 7 unknown, 3 recruiting, 1 enrolling by invitation. 9 Phase 4, 8 Not applicable, 6 Phase 3, 4 Phase 2, 2 Phase 1.
Follow Cefotaxime: new trials by email Literature Review of Cefotaxime trials Research Report on Cefotaxime
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Duration of Perioperative Antibiotics in Pancreatoduodenectomy single dose preoperative antibiotic, Prolonged perioperative antibiotics - Pancreatoduodenectomy, PPPD | Not applicable | Enrolling by invitation | Asan Medical Center | 558 | 2026-05-11 | 2026-05-28 |
| Aminoglycosides in Early Sepsis Gentamicin + narrow spectrum betalactam, Cefotaxime, Piperacillin-tazobactam - Sepsis | Phase 4 | Recruiting | University Hospital, Akershus | 1900 | 2026-04-23 | 2026-10-28 |
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-11-12 |
| Meropenem vs Cefotaxime as Empirical Treatment of SBP cefotaxime - Spontaneous Bacterial Peritonitis | Phase 4 | Unknown | Assiut University | 286 | 2023-01-01 | 2022-06-22 |
| LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media 0.9% NaCl physiological saline Nasal-spraying, LiveSpo Navax®, Augmentin 500Mg Tablet - Upper Respiratory Tract Infections | Not applicable | Completed | Anabio R&D | 175 | 2021-10-28 | 2024-08-22 |
| Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria Oral Paste(0,5 g) containing 10 mg of polymyxin B, 10 mg of gentamycin and 150 mg of amphotericine B or 500 000 U of nistatin q6h, Suspension (10 ml) containing 100 mg of polymyxin B, 80 mg of gentamycin, 350 mg of amphotericine B or 8000000 U of nistation and 500 mg of vancomycin q6h, Intravenous Antibacterial Agent - a 3-day course of systemic cefotaxime 1 g q6h or ceftriaxone 1 g qd - Pneumonia, Ventilator-Associated, Pneumonia | Not applicable | Unknown | MEDSI Clinical Hospital 1, ICU | 60 | 2021-05-01 | 2021-06-08 |
| Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute | Phase 2 / Phase 3 | Completed | Haiphong University of Medicine and Pharmacy | 170 | 2020-01-01 | 2021-05-10 |
| Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria Cefotaxime, Ceftriaxone - Infection, Bacterial | Not applicable | Completed | Fondation Hôpital Saint-Joseph | 34 | 2019-04-30 | 2021-08-16 |
| Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis Cefotaxime, Gemifloxacin - Spontaneous Bacterial Peritonitis | Phase 3 | Recruiting | Tanta University | 60 | 2018-12-01 | 2019-11-19 |
| Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT) Cefotaxime Injection, Rectal swab, Cefotaxime/ceftriaxone - Infectious Disease - Resistant Enterobacteriaceae (Diagnosis) | Phase 4 | Unknown | Centre Hospitalier Universitaire de Besancon | 250 | 2018-04-03 | 2019-04-22 |
| Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients SDD Oral Paste, SDD Gastric Suspension, Intravenous Antibiotic - Critical Illness, Sepsis | Phase 3 | Completed | The George Institute | 20010 | 2017-05-01 | 2023-08-14 |
| Antibiotic "Dysbiosis" in Preterm Infants Antibiotic, Gastric fluid, Breast milk - Enterocolitis, Necrotizing, Bacteremia | Phase 2 | Completed | University of Florida | 98 | 2017-01-16 | 2024-06-05 |
| Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections Temocillin, Cefotaxime - Urinary Tract Infections | Phase 4 | Completed | Håkan Hanberger | 157 | 2016-05-20 | 2019-09-16 |
| The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin, Appendectomy - Appendicitis | Not applicable | Completed | University of Washington | 1552 | 2016-05-01 | 2023-05-06 |
| Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal. ceftriaxone, Cefotaxime - Emergence of Bacterial Resistance to Antibiotics | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 22 | 2016-03-01 | 2018-05-21 |
| Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU. Cefotaxime - Critically Ill | Phase 4 | Completed | University Medical Center Groningen | 60 | 2015-11-01 | 2016-10-27 |
| Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis Cefotaxime - Spontaneous Bacterial Peritonitis | Not applicable | Completed | Dr Ahmed Ali Elbaz | 254 | 2015-03-01 | 2015-06-04 |
| Laparoscopic Appendectomy for Uncomplicated Appendicitis: Does Antimicrobial Prophylaxis Really Matter? cefamezin 1g IV, metronidazole 500 mg IV, Placebo - Appendicitis | Not applicable | Unknown | HaEmek Medical Center, Israel | 288 | 2015-03-01 | 2015-03-31 |
| Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins? Cefotaxime, ceftriaxone - Primary Bacterial Peritonitis | Phase 3 | Unknown | Tanta University | 100 | 2015-01-01 | 2017-06-20 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
Showing 20 of 29. Sign in to see all of them.
Sepsis (4) · Appendicitis (3) · Critical Illness (3) · Pneumonia, Ventilator-Associated (3) · Bacterial Infections (2) · Respiratory Tract Infections (2) · Anaphylaxis (1) · Bacteremia (1) · Brain Injuries (1) · Bronchopulmonary Dysplasia (1) · Coinfection (1) · Diabetes Mellitus (1) · Disease (1) · Drug Hypersensitivity (1) · Enterocolitis, Necrotizing (1)
Centre Hospitalier Universitaire de Besancon (2) · Tanta University (2) · Anabio R&D (1) · Asan Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Dr Ahmed Ali Elbaz (1) · Fondation Hôpital Saint-Joseph (1) · Göteborg University (1) · HaEmek Medical Center, Israel (1) · Haiphong University of Medicine and Pharmacy (1) · Håkan Hanberger (1) · Jinling Hospital, China (1) · Julio Ramirez (1) · Korea University (1)
France (5) · United States (4) · Egypt (3) · Italy (2) · South Korea (2) · Sweden (2) · Vietnam (2) · Australia (1) · Canada (1) · China (1) · Netherlands (1) · Norway (1) · Russia (1) · United Kingdom (1)
Alina Tone, MD (1) · Anthony Gordon, MD FRCA (1) · Binh Nguyen Thanh, Assoc. Prof. (1) · Brian Cuthbertson, MD FRCA (1) · Claudio Puoti, Prof (1) · Dan Hershko, Professor (1) · David A Khan, MD (1) · David A Talan, MD (1) · David R Flum, MD, MPH (1) · David Seligson, MD (1) · Dmitry Azovskiy, MD, phD (1) · Eric M Senneville, MD, PhD (1)
PMID 15276398, PMID 15840453, PMID 16291576, PMID 19358184, PMID 19588358, PMID 21129208, PMID 22147550, PMID 22530208, PMID 22952580, PMID 23352693, PMID 24207137, PMID 25414157, PMID 26445823, PMID 26529126, PMID 28846337, PMID 28876707, PMID 29146633, PMID 30881387, PMID 30936104, PMID 31697336, PMID 33479274, PMID 35612859, PMID 35796152, PMID 35815898, PMID 36197656, PMID 36286097, PMID 36594820, PMID 37308133, PMID 37379001, PMID 37982826, PMID 38045525, PMID 39373498, PMID 39870748, PMID 41159880, PMID 42642777, PMID 4902833, PMID 8948280
2014 (1), 2015 (1), R21HD088005 (1), U01AI184071 (1)